Thank you, Mr. Chair.
I'd like to thank our witnesses for their testimony today.
I'll start with Mr. Prouse, or perhaps Mr. Affleck, in relation to regulatory reform. I think this will be important writ large, beyond agriculture, in the days ahead. We'll probably have challenges on the fiscal framework on the other side of the pandemic, and we will have to look at creative ways to help drive economic activity.
You mentioned, of course, trying to clarify or create a regulatory pathway. What does that look like right now? I understand that other countries look at processing, at the actual tools you are using, the gene editing tools, and Canada looks at the end product and whether or not it's safe. Can you quickly explain a bit about that?